Cresilon representatives will be available to talk about how TRAUMAGEL can be easily deployed to control bleeding in seconds across emergency response and military environments at the poster session ...
- Data from the ASCENT study of LIQ861 (YUTREPIA™) in PH-ILD patients highlights safety, tolerability, exploratory changes in six-minute walk distance, cardiac effort and quality of life - Case study ...
PharmaJet needle-free technology can improve DNA vaccine delivery 1 and has been successfully adopted into multiple cancer vaccine development programs. Partner study data shows how PharmaJet ...
Preclinical in vitro studies demonstrated >80% reduction in protease activity, including complete inhibition of TACE and collagenase — key factors in non-healing chronic wounds revyve® data featured ...
Fewell, L.K. & Nanney, J. Modified CPT for COVID-related posttraumatic stress disorder: A case study. Poster Presentation at the 37th Annual International Society for ...
Clinical case series showed clinically meaningful reductions in wound size and pain, and improved tissue regranulation in chronic wound patients using revyve ® over 6–12 weeks Preclinical in vitro ...
Preclinical in vitro studies demonstrated >80% reduction in protease activity, including complete inhibition of TACE and collagenase - key factors in non-healing chronic wounds revyve ® data featured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback